(24/7 MARKET NEWS) – Oncolytics Biotech Inc. (NASDAQ: ONCY) reported interim results from the phase 1/2 GOBLET study's first-line advanced/metastatic...
Read more(24/7 MARKET NEWS) – Rubius Therapeutics Inc. (NASDAQ: RUBY) remains active in this morning’s premarket. Although its trading 2 cents...
Read moreAtlanta, GA , April 28, 2022 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI, Euronext Growth: AIID ID), the Privacy-First Identity...
Read more